This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Smart Start, Inc.
Global Leader in Alcohol Monitoring Services Technology Launches SMARTOX™ Drug Screens and Lab Services; Related Services with Intelligent Fingerprinting Available in 2013.
Irving, Texas (PRWEB) November 28, 2012
Building on its record as a trusted, reliable and accurate technology provider to the criminal justice, law enforcement and judiciary sectors, Smart Start, Inc. today launched its new SMARTOX™ drug screening products for use in these sectors, as well as in the healthcare and corporate drug testing industries. The SMARTOX™ line consists of competitively priced urine and oral fluid instant screening tests for drugs of abuse.
Included is the innovative SMARTOX™ U3 point of collection urine drug screen cup. The keyless, split sample cup features an advanced leak-proof lid, making the U3 the most user and collector friendly urine test cup on the market.
“Many of our law enforcement community clients asked for a Smart Start solution in screening for drugs of abuse,” said Jim Ballard, president of Smart Start, Inc. “Expanding into this closely related, complementary line of services makes great sense for our monitoring agency clients.”
In 2013, Smart Start will release another complementary drug screening product in concert with British company Intelligent Fingerprinting Ltd. Earlier this year, Smart Start obtained exclusive rights to distribute Intelligent Fingerprinting’s drugs of abuse detection products in North America. The fingerprint drug screen device utilizes patented nanoparticle technology and is expected to revolutionize the drug testing industry. Needing only a fingerprint sample, the non-invasive device can detect drugs of abuse while also confirming and storing the user’s identity. It provides rapid results in less than 10 minutes using a portable hand-held device. Smart Start will manage U.S. market testing of the instant drug screen product.
Ballard added, “With our new SMARTOX™ line and the very promising Intelligent Fingerprinting products, Smart Start is well positioned to build on our alcohol monitoring market leadership to become a trusted, leading provider of drug testing products and services.”
Smart Start expects the Intelligent Fingerprinting product to reduce the need for urine and oral drug testing in the future. Pending regulatory approval, the product will be available for widespread use in domestic and international markets.
Smart Start will utilize its extensive distribution network and established industry relationships developed with its alcohol monitoring products to promote the new drug screening and lab testing products.
About Smart Start:
Privately held Smart Start, Inc. is a leader in alcohol monitoring through its ignition interlock and IN-HOM® alcohol testing devices and its SMARTOX™ drug screening products and services. It provides fully integrated services encompassing design, manufacturing, installation, customer service, monitoring and administrative support for its alcohol monitoring products. The company’s line of drug screening products were introduced in 2012. A leading global supplier of alcohol monitoring devices and drug screening services since its creation in 1993, Smart Start is headquartered in Irving, Texas, and offers its products and services through more than 1,000 company-owned and franchised locations in the United States, Europe, Latin America, New Zealand, and Australia.
For more info on Smart Start, visit http://www.smartstartinc.com.
For more info on SMARTOX products, visit http://www.smartox.com.
About Intelligent Fingerprinting:
Intelligent Fingerprinting Ltd. has developed unique technology to determine whether an individual is using drugs from analyzing minute traces of sweat deposited in their fingerprints. The fingerprint itself provides positive identification of the individual and the sweat analysis indicates the presence of drugs in the body. The non-invasive technology detects the products of the body’s metabolism of the drug (so-called ‘metabolites’) and not the drug itself, and therefore provides direct evidence that the person has actually taken the drugs, and not simply touched a surface that might have been contaminated. In addition to the detection of drugs of abuse, the Intelligent Fingerprinting technology can be used for a wide range of other applications. The company was recently awarded nearly USD $700,000 in research grants by the UK Ministry of State for Universities and Science to further support development of its technology. This additional funding will help accelerate the time to market and ensure organizations will receive the unique benefits of the Intelligent Fingerprinting product.
For more info on Intelligent Fingerprinting, visit http://www.intelligentfingerprinting.com/.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/11/prweb10177541.htm